Source comparison
CJC-1295 Signaling Pathway: Comparison Table
CJC-1295 DAC 6–8 days 1–2× per week Moderate (1.5–2× baseline) sustained over 7–10 days Sustained elevation (50–100% above baseline for duration) Long-term metabolic studies, aging research, body composition protocols CJC-1295 no-DAC (Mod GRF 1-29) 30 minutes
This comparison does not assign a generated winner or score.
- CJC-1295 DAC
- 6–8 days
- 1–2× per week
- Moderate (1.5–2× baseline) sustained over 7–10 days
- Sustained elevation (50–100% above baseline for duration)
- Long-term metabolic studies, aging research, body composition protocols
- CJC-1295 no-DAC (Mod GRF 1-29)
- 30 minutes
- 2–3× daily
- High (2–4× baseline) for 60–90 minutes post-dose
- Transient spikes aligned with dosing
- Acute GH response studies, exercise physiology, sleep architecture research
- Native GHRH (1-44)
- Under 7 minutes
- Continuous infusion or multiple daily boluses
- High but very brief (minutes)
- Minimal. Clearance too rapid for sustained IGF-1 synthesis
- Diagnostic testing (GH reserve assessment), not practical for research interventions